Evidence map›Paper›PMID 36329394›Full record

ArticleBMC cancer2022

Prognostic significance of prognostic nutritional index and systemic immune-inflammation index in patients after curative breast cancer resection: a retrospective cohort study.

Tai Xu, Si-Ming Zhang, He-Ming Wu, Xiao-Min Wen, Dong-Qin Qiu, Yu-Yang Yang, Li-Zhen Wang, Wen-Biao Zhu, Li-Shan He, Jian-Juan Li

Abstract read
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Prognostic value of prognostic nutritional index in patients with nasopharyngeal carcinoma treated with endostar and concurrent chemoradiotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tai XuDepartment of Breast Surgery, Meizhou People's Hospital, No.63 Huangtang Road, Meijiang District, Meizhou, Guangdong, 541000, People's Republic of China. xutai2005@sina.com.
Si-Ming ZhangDepartment of Breast Surgery, Meizhou People's Hospital, No.63 Huangtang Road, Meijiang District, Meizhou, Guangdong, 541000, People's Republic of China.
He-Ming WuGuangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou People's Hospital, Meizhou, Guangdong, People's Republic of China.
Xiao-Min WenClinical Laboratory Center, Meizhou People's Hospital, Meizhou, Guangdong, People's Republic of China.
Dong-Qin QiuDepartment of Breast Surgery, Meizhou People's Hospital, No.63 Huangtang Road, Meijiang District, Meizhou, Guangdong, 541000, People's Republic of China.
Yu-Yang YangDepartment of Breast Surgery, Meizhou People's Hospital, No.63 Huangtang Road, Meijiang District, Meizhou, Guangdong, 541000, People's Republic of China.
Li-Zhen WangDepartment of Breast Surgery, Meizhou People's Hospital, No.63 Huangtang Road, Meijiang District, Meizhou, Guangdong, 541000, People's Republic of China.
Wen-Biao ZhuDepartment of Pathology, Meizhou People's Hospital, Meizhou, Guangdong, People's Republic of China.
Li-Shan HeClinical Pharmaceutics Room, Meizhou People's Hospital, Meizhou, Guangdong, People's Republic of China.
Jian-Juan LiDepartment of Breast Surgery, Meizhou People's Hospital, No.63 Huangtang Road, Meijiang District, Meizhou, Guangdong, 541000, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNutritional status and inflammation are closely associated with poor outcome in malignant tumors. However, the prognostic impact of postoperative in these variables on breast cancer (BC) remains inconclusive. We aimed to determine whether prognostic nutritional index (PNI), systemic immune-inflammation index (SII), neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) affect two long-term outcomes among patients after curative resection of BC.

methodsWe retrospectively reviewed 508 patients with BC treated with curative surgery between February 5, 2013 and May 26, 2020. All patients were divided into 3 groups based on tertiles (T1-T3) of PNI, SII, NLR, and PLR. The effects of four indexes on disease-free survival (DFS) and overall survival (OS) have been evaluated using Cox proportional hazards models and Kaplan-Meier method.

resultsCompared with PNI-lowest cases, patients with highest PNI showed significantly longer DFS (multivariate adjusted hazard ratio [HR] = 0.37, 95% confident interval [CI] 0.19-0.70, P for trend = 0.002), whereas higher PLR seemed to be marginally associated with poorer DFS (P for trend = 0.086 and 0.074, respectively). Subgroup analyses indicate the potential modification effects of family history of BC and radiotherapy on the prognosis value of PNI to DFS in BC patients (P for interaction = 0.004 and 0.025, respectively). In addition, the levels of three inflammatory indices, namely SII, NLR, and PLR might be positively related with increased age at diagnosis (all P for trend < 0.001).

conclusionsA high PNI was associated with better DFS, supporting its roles as prognostic parameters for patients with BC. The nutritional status and systemic immune may exert great effects on patient prognosis. Further studies are warrant to explore the prognosis value of PLR.

Indexed as

Breast NeoplasmsNutrition AssessmentFemaleHumansInflammationLymphocytesNeutrophilsPrognosisRetrospective StudiesBreast cancerNeutrophil–lymphocyte ratioPlatelet-lymphocyte ratioPrognostic nutritional indexSystemic immune-inflammation index

Identifiers

PMID36329394
PMCPMC9632068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.